Cencora, Inc. (COR) stock
CORNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 14/3022% above fair value
$349.88+1.17 (+0.34%)
Close on Nov 11, 2026Market cap $66.77BP/E 26.0Yield 0.63%
Cencora enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Cencora's enterprise value was $75.86B on Nov 11, 2026, against $75.09B a year earlier. Over the last 5 years it ranged from $31.45B to $78.75B, with a median of $48.76B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $75.86B | +9.9% |
| 2025 | Dec 31, 2025 | $69.05B | +52.8% |
| 2024 | Dec 31, 2024 | $45.20B | +3.7% |
| 2023 | Dec 29, 2023 | $43.58B | +18.5% |
| 2022 | Dec 30, 2022 | $36.77B | +14.4% |
| 2021 | Dec 31, 2021 | $32.15B | +63.5% |
| 2020 | Dec 31, 2020 | $19.67B | +6.4% |
| 2019 | Dec 31, 2019 | $18.49B | +3.9% |
| 2018 | Dec 31, 2018 | $17.80B | -15.3% |
| 2017 | Dec 29, 2017 | $21.02B | +12.7% |
| 2016 | Dec 30, 2016 | $18.65B | -18.1% |
| 2015 | Dec 31, 2015 | $22.78B | +12.8% |
| 2014 | Dec 31, 2014 | $20.19B | +23.6% |
| 2013 | Dec 31, 2013 | $16.34B | +55.7% |
| 2012 | Dec 31, 2012 | $10.49B | +13.5% |
| 2011 | Dec 30, 2011 | $9.25B | +1.0% |
| 2010 | Dec 31, 2010 | $9.15B | +19.3% |
| 2009 | Dec 31, 2009 | $7.67B | – |
See a number that looks wrong?